OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0938-AQ41         View EO 12866 Meetings	Received Date: 08/04/2015
Title: Covered Outpatient Drugs (CMS-2345-F)
Agency/Subagency: HHS / CMS	Stage: Final Rule
Concluded Action: Consistent with Change	Concluded Date: 12/11/2015
Legal Deadline: Statutory	Economically Significant: Yes
Publication Date: 02/01/2016	Unfunded Mandates: No
Major: Yes	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: Yes	Small Entities Affected: Businesses
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: Yes
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: Uncollected